The9 LTD: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Apr 16, 2026 and accepted by EDGAR at Apr 15, 2026, 19:39 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $15.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2025-01-01 to 2025-12-31 | $15.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2025-01-01 to 2025-12-31 | $259.0k | us-gaap:GrossProfit |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$40.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $3.3m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | $16.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$58.5m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 2,273,782,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$4.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-12-31 | $8.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $49.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $84.9m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $49.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $50.2m | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-12-31 | $24.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-12-31 | $27.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-12-31 | 4,567,660,012 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-26-043910. Last ingested by Listed: Nov 2, 2026, 06:20 ET. Listed shows no prices and gives no investment advice.